Małgorzata Kujawska, PhD, DSc, is an Associate Professor at Poznan University of Medical Sciences. She graduated with an MSc. and Ph.D. with a postdoctoral degree (habilitation) in pharmaceutical sciences. Her research work has been focused on the protective effects of substances of natural origin, which have the potential to optimize health status and reduce the risk of civilization's diseases. Her ongoing research interest is the implication of the Gut-Microbiome-Brain Axis in neurodegeneration and neuroprotection, also with the use of Quantum Technologies. She is was awarded The Polish Intelligent Development Award 2020 in the category of Scientist of The Future. Dr. Kujawska is a recipient of the 2020 Matsumae International Foundation Research Fellowship Program. She completed workshops on entrepreneurship and design thinking at Stanford University within the prestigious government program "Top 500 Innovators" and International Summer School on Technology Transfer in Life Sciences (Technische Universität Dresden). She took part in an internship at NASA Ames Research Center at Synthetic Biology Innovation Lab. Dr. Kujawska is in the Top 1% of reviewers for pharmacology & toxicology and cross-field, according to Publons (Web of Science). She is a member of an editorial board and review panels for several scientific journals. She also served as a scientific evaluator for agencies financing R&D activities in the field of healthcare and biomedical technologies.